All
Search
Images
Videos
Maps
News
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Top suggestions for Durvalumab Immunotherapy
Immunotherapy
Procedure
Durvalumab
by Imfinzi
Immunotherapy
Infusion
Immunotherapy
Animation
Durvalumab Immunotherapy
Lung Cancer
Immunotherapy
AG
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Immunotherapy
Procedure
Durvalumab
by Imfinzi
Immunotherapy
Infusion
Immunotherapy
Animation
Durvalumab Immunotherapy
Lung Cancer
Immunotherapy
AG
0:34
Facebook
Moffitt Cancer Center
The FDA has expanded its approval of Imfinzi® (durvalumab), to include stage III non-small cell lung cancer patients. The immunotherapy was approved for bladder cancer last year,
Moffitt Cancer Center. . The FDA has expanded its approval of Imfinzi® (durvalumab), to include stage III non-small cell lung cancer patients. The immunotherapy was approved for bladder cancer last year, but Moffitt’s Dr. Scott Antonia saw the potential of Imfinzi as a treatment option for lung cancer patients. He launched a global clinical ...
4.7K views
Feb 20, 2018
Related Products
Durvalumab Immunotherapy Lung Cancer
Immunotherapy Procedure
Mesothelioma Immunotherapy
#Durvalumab Side Effects
Side Effects of Immunotherapy: What to Know
cancerresearch.org
5 months ago
Immunotherapy Side Effects: When to Call Your Doctor
WebMD
Feb 29, 2024
Top videos
FDA Approval of Durvalumab for Advanced Bladder Cancer
onclive.com
Apr 22, 2017
Dr. Sonpavde on Fixed-Dose Durvalumab and Tremelimumab Study in Urothelial Carcinoma
onclive.com
Feb 10, 2018
2:43
FDA Approves Durvalumab / Imfinzi for Resectable NSCLC Non-Small Cell Lung Cancer
YouTube
OncologyTube
3.3K views
Sep 12, 2024
Durvalumab Uses
0:26
To license this content please click here: https://www.jukinmedia.com/licensing/view/1411372?utm_source=RMsocialpost&utm_medium=RMsocialpost | Jukin Copyright Management | Facebook
Facebook
Jukin Copyright Management
1.8M views
1 week ago
1:04
14M views · 787 reactions | Giving your dog a bath doesn’t have to be a struggle anymore . Via In The Know Delights | AOL | Facebook
Facebook
AOL
14.7M views
2 weeks ago
5:12
1.2M views · 10K reactions | The UK's last aerial ropeway uses no power, moves 300 tonnes a day, and will be gone by 2036. - In Claughton, Lancashire, the Forterra brickworks produces 50 million bricks a year, from shale that's quarried a mile and a half away. To get that shale to the brickworks: the last aerial ropeway in the country. These used to be common: but now, the last one will be gone by 2036. | Tom Scott | Facebook
Facebook
Tom Scott
854.8K views
1 week ago
FDA Approval of Durvalumab for Advanced Bladder Cancer
Apr 22, 2017
onclive.com
Dr. Sonpavde on Fixed-Dose Durvalumab and Tremelimumab S
…
Feb 10, 2018
onclive.com
2:43
FDA Approves Durvalumab / Imfinzi for Resectable NSCLC Non-Small
…
3.3K views
Sep 12, 2024
YouTube
OncologyTube
3:07
The Use of Durvalumab in Locally Advanced NSCLC
261 views
Apr 16, 2018
YouTube
Targeted Oncology
6:29
Durvalumab ( Imfinzi ) for HCC
264 views
Aug 15, 2024
YouTube
PharmComm
4:25
Durvalumab Tolerability in Non–Small Cell Lung Cancer
1.3K views
Feb 25, 2020
YouTube
Targeted Oncology
5:25
Durvalumab Plus BCG: A New Hope for High-Risk Non-Muscle Invasiv
…
1 views
1 month ago
YouTube
All Sides Now
1:39
Durvalumab mode of action
824 views
Jan 28, 2023
YouTube
Asif Biotech
2:03
Durvalumab FDA Approval for Bladder Cancer
216 views
May 5, 2017
YouTube
OncLive
7:44
Durvalumab (Imfinzi) FDA Approved for Stage III NSCLC: Standard of C
…
2.9K views
Feb 20, 2018
YouTube
BeaconMedIC
10:01
SCLC Immunotherapy: Durvalumab Breakthroughs & Biomarker Chall
…
1 views
2 months ago
YouTube
The Creative Flow
Durvalumab: A Review in Extensive-Stage SCLC
Jan 27, 2020
nih.gov
0:08
GO2 for Lung Cancer on Instagram: "📢 The @fda has approved Imfinzi (
…
581 views
Dec 6, 2024
Instagram
go2forlungcancer
3:02
Durvalumab Plus BCG: A New Hope for High-Risk Bladder Cancer?
3 views
1 month ago
YouTube
Universal Moments
7:47
Durvalumab and BCG: A New Treatment Option for High-Risk Bl
…
1 views
1 month ago
YouTube
The Open Forum
8:28
Imfinzi Uses: Guide to Understanding the Many Benefits
…
1.4K views
Sep 11, 2023
YouTube
Inevid
52:55
Immunotherapy Nightmare - Imfinzi/Durvalumab Experience - L
…
400.5K views
Sep 18, 2022
YouTube
The Apples
0:58
An Expert’s Thoughts on the FDA Approval of Durvalumab in Locall
…
361 views
Apr 9, 2018
YouTube
Targeted Oncology
1:06
The Mechanism of Action of Durvalumab in the Treatment of Ur
…
1.4K views
Aug 10, 2016
YouTube
Targeted Oncology
2:36
Exploring Durvalumab With Radiation Therapy in Patients Wit
…
87 views
Feb 9, 2018
YouTube
Targeted Oncology
2:15
The impact of durvalumab for resectable non-small cell lung can
…
434 views
Sep 26, 2024
YouTube
VJOncology
2:31
Perioperative Durvalumab in Bladder Cancer | NEJM
1.3K views
Nov 14, 2024
YouTube
NEJM Group
1:17
The impact of durvalumab on the SCLC treatment landscape
298 views
9 months ago
YouTube
VJOncology
6:04
Durvalumab plus chemotherapy significantly improved OS in adva
…
1.4K views
Mar 21, 2022
YouTube
ecancer
1:22
Evaluating durvalumab and chemotherapy for MIBC in the NIA
…
46 views
1 month ago
YouTube
VJOncology
0:59
Can you use Durvalumab with Lurbinectedin in Maintenance Par
…
563 views
4 months ago
YouTube
OncBrothers: Practice-Changing Cancer Discus…
1:08
Neoadjuvant Durvalumab Shows Benefit in Triple-Negative Breast C
…
420 views
Jan 2, 2020
YouTube
Targeted Oncology
2:51
Imfinzi Approved: A Breakthrough in Early Gastric and GEJ Cancer Tre
…
1 month ago
YouTube
One Voice Universe
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carci
…
213 views
Jun 6, 2022
nejm.org
See more videos
More like this
Feedback